# 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

> **NCT02966145** · — · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 293 (actual)

## Conditions studied

- Corticobasal Degeneration (CBD)
- Corticobasal Syndrome (CBS)
- Cortical-basal Ganglionic Degeneration (CBGD)
- Progressive Supranuclear Palsy (PSP)
- Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
- Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)

## Interventions

- **OTHER:** Observational Study

## Key facts

- **NCT ID:** NCT02966145
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 293 (ACTUAL)
- **Last updated:** 2025-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966145, "4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02966145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*